Metachromatic Leukodystrophy
Metachromatic Leukodystrophy: Introduction
Metachromatic Leukodystrophy:
Metachromatic leukodystrophy (MLD) is a genetic
disorder caused by a deficiency of the enzyme arylsulfatase A. It is one
of a group of ... more about Metachromatic Leukodystrophy.
Metachromatic Leukodystrophy: An inherited biochemical deficiency involving a deficiency of the enzyme called arylsulfatase A which leads to a harmful buildup of fatty material in the body.
More detailed information about the symptoms,
causes, and treatments of Metachromatic Leukodystrophy is available below.
Symptoms of Metachromatic Leukodystrophy
See full list of 37
symptoms of Metachromatic Leukodystrophy
Treatments for Metachromatic Leukodystrophy
Read more about treatments for Metachromatic Leukodystrophy
Home Diagnostic Testing
Home medical testing related to Metachromatic Leukodystrophy:
- Nerve Neuropathy: Related Home Testing:
- Brain & Neurological Disorders: Related Home Testing:
- more...»
Wrongly Diagnosed with Metachromatic Leukodystrophy?
Metachromatic Leukodystrophy: Related Patient Stories
Types of Metachromatic Leukodystrophy
- Late infantile MLD - most common form
- Juvenile MLD
- Adult MLD
- more types...»
Read more about Types of Metachromatic Leukodystrophy
Metachromatic Leukodystrophy: Complications
Review possible medical complications related to Metachromatic Leukodystrophy:
Causes of Metachromatic Leukodystrophy
Read more about causes of Metachromatic Leukodystrophy.
Disease Topics Related To Metachromatic Leukodystrophy
Research the causes of these diseases that are similar to, or related to, Metachromatic Leukodystrophy:
Metachromatic Leukodystrophy: Undiagnosed Conditions
Commonly undiagnosed diseases in related medical categories:
Misdiagnosis and Metachromatic Leukodystrophy
Undiagnosed stroke leads to misdiagnosed aphasia: BBC News UK reported on a man who
had been institutionalized and treated for mental illness
because he suffered from sudden...read more »
Dementia may be a drug interaction: A common scenario in aged care is for
a patient to show mental decline to dementia.
Whereas this can, of course, occur due to various medical conditions,
such as a ...read more »
Mild traumatic brain injury often remains undiagnosed: Although the symptoms
of severe brain injury are hard to miss,
it is less clear for milder injuries, or even those causing a mild ...read more »
MTBI misdiagnosed as balance problem: When a person has symptoms
such as vertigo or dizziness, a diagnosis of brain injury may go overlooked.
This is particularly true of ...read more »
Brain pressure condition often misdiagnosed as dementia: A condition
that results from an excessive pressure of CSF within the brain is often misdiagnosed.
It...read more »
Post-concussive brain injury often misdiagnosed: A study found that soldiers who had
suffered a concussive injury in battle often were misdiagnosed on their return.
A variety of...read more »
Children with migraine often misdiagnosed: A migraine often fails to be
correctly diagnosed in pediatric patients.
These patients are not the typical migraine sufferers, but migraines...read more »
Vitamin B12 deficiency under-diagnosed: The condition of Vitamin B12 deficiency
is a possible misdiagnosis of various conditions, such as multiple sclerosis (see symptoms of...read more »
Read more about Misdiagnosis and Metachromatic Leukodystrophy
Metachromatic Leukodystrophy: Research Doctors & Specialists
Research related physicians and medical specialists:
- Nerve Specialists:
- Neurology (Brain/CNS Specialists):
- Stroke & Vascular Specialists:
- more specialists...»
Other doctor, physician and specialist research services:
Metachromatic Leukodystrophy: Rare Types
Rare types of diseases and disorders in related medical categories:
Evidence Based Medicine Research for Metachromatic Leukodystrophy
Medical research articles related to Metachromatic Leukodystrophy include:
Click here to find more evidence-based articles on the TRIP Database
Metachromatic Leukodystrophy: Animations
More Metachromatic Leukodystrophy animations & videos
Prognosis for Metachromatic Leukodystrophy
Prognosis for Metachromatic Leukodystrophy:
Poor. Life-shortening. Often death 3-6 years after onset for infantile form; death within 6-14 years of onset for other forms.
More about prognosis of Metachromatic Leukodystrophy
Research about Metachromatic Leukodystrophy
Visit our research pages for current research about Metachromatic Leukodystrophy treatments.
Clinical Trials for Metachromatic Leukodystrophy
The US based website ClinicalTrials.gov lists information on both federally
and privately supported clinical trials using human volunteers.
Some of the clinical trials listed on ClinicalTrials.gov for Metachromatic Leukodystrophy include:
Read more about Clinical Trials for Metachromatic Leukodystrophy
Statistics for Metachromatic Leukodystrophy
Metachromatic Leukodystrophy: Broader Related Topics
Types of Metachromatic Leukodystrophy
Metachromatic Leukodystrophy Message Boards
Related forums and medical stories:
User Interactive Forums
Read about other experiences, ask a question about Metachromatic Leukodystrophy, or answer someone else's question, on our message boards:
Article Excerpts about Metachromatic Leukodystrophy
Metachromatic leukodystrophy (MLD) is a genetic
disorder caused by a deficiency of the enzyme arylsulfatase A. It is one
of a group of genetic disorders called the leukodystrophies that affect
growth of the myelin sheath, the fatty covering -which acts as an
insulator - on nerve fibers in the brain.
(Source: excerpt from NINDS Metachromatic Leukodystrophy Information Page: NINDS)
Definitions of Metachromatic Leukodystrophy:
An autosomal recessive lysosomal storage disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to an accumulation of cerebroside sulfate in the nervous system and other organs. Pathologic features include diffuse demyelination and metachromatically-staining granules within glial cells, macrophages, and free in tissue. Clinical subtypes include late infantile, juvenile, and adult forms. The late infantile form presents at 12-18 months of age with progressive psychomotor retardation, ATAXIA, spasticity, and OPTIC ATROPHY. The juvenile form has onset at 4-12 years and features behavioral alterations and ataxia followed by spasticity, DEMENTIA, and visual loss. The adult form presents in the second decade or later with psychiatric manifestations, gait difficulties, and less often as a peripheral neuropathy. (From Menkes, Textbook of Child Neurology, 5th ed, pp192-5)
- (Source - Diseases Database)
Metachromatic Leukodystrophy is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Metachromatic Leukodystrophy, or a subtype of Metachromatic Leukodystrophy,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Metachromatic Leukodystrophy as a "rare disease".
Source - Orphanet
Contents for Metachromatic Leukodystrophy:
User Surveys and Discussion Forums